Efficacy and Safety of MT1013 compared to Etelcalcetide in patients with Secondary Hyperparathyroidism undergoing Maintenance Dialysis

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/25f0b4017f71935a9caf815e648110e0.pdf
Efficacy and Safety of MT1013 compared to Etelcalcetide in patients with Secondary Hyperparathyroidism undergoing Maintenance Dialysis

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Ping
Zhang
Ping Zhang 13588016833@163.com The First Affiliated Hospital of Medical School of Zhejiang University Department of Nephrology Hangzhou China *
Jianghua Chen chenjianghua@zju.edu.cn The First Affiliated Hospital of Medical School of Zhejiang University Department of Nephrology Hangzhou China -
Bing Wang wangbing@micot.cn Shaanxi Micot Technology Limited Company CEO Xi'an China -
Xiangling Wang xiangling1116@163.com Shaanxi Micot Technology Limited Company CMO Beijing China -
Linyuan Wang linyuanw@pku.org.cn Shaanxi Micot Technology Limited Company Medical Department Shanghai China -
Zhian Huang huang6693504@126.com Shaanxi Micot Technology Limited Company Marketing Department Shanghai China -
Yu Zhi yuzhi3039@163.com Shaanxi Micot Technology Limited Company Department of Clinical Operation Shanghai China -
Lanlan Song songlanlan@micot.cn Shaanxi Micot Technology Limited Company Department of Clinical Operation Xi'an China -
Ruiling Wang wangruiling@micot.cn Shaanxi Micot Technology Limited Company Department of Clinical Pharmacology Xi'an China -
Xiaodong Wang 15140186875@163.com Shaanxi Micot Technology Limited Company Medical Department Shanghai China -
Hao Yu 516333049@qq.com Shaanxi Micot Technology Limited Company Department of Clinical Operation Shanghai China -
Chong Luo luochongqx@zju.edu.cn The First Affiliated Hospital of Medical School of Zhejiang University Department of Nephrology Hangzhou China -
-
-
-